Annual report pursuant to Section 13 and 15(d)

CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited)

v3.22.1
CONDENDSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Class A/B
Subordinate Voting Shares
Super Voting Shares
Share Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2018   28,497        
Balance, amount at Dec. 31, 2018 $ 32,640       $ 54,333 $ (21,693)
Net loss (49,934)   $ 0 $ 0 0 (49,934)
Adoption of lease accounting standard (847) $ 0   $ 0 0 (847)
Issuance of subordinate voting shares in exchange for Class A/B shares, net, shares   (28,497) 28,497      
Issuance of subordinate voting shares in exchange for Class A/B shares, net, amount         0 0
Private placement in connection with reverse takeover, net, shares     3,433      
Private placement in connection with reverse takeover, net, amount $ 36,762       36,762  
Shares issued to acquiree in connection with reverse takeover, shares 1,513   130      
Shares issued to acquiree in connection with reverse takeover, amount $ 1,513       1,513  
Issuance of super voting shares, shares       203    
Issuance of super voting shares, amount 40       40  
Exercise of options, shares     125      
Exercise of options, amount 127       127  
Share-based compensation expense, shares     659      
Share-based compensation expense, amount 3,385       3,385  
Balance, shares at Dec. 31, 2019     32,844 203    
Balance, amount at Dec. 31, 2019 23,686       96,160 (72,474)
Net loss (21,910) $ 0 $ 0 $ 0 0 (21,910)
Share-based compensation expense, shares     248      
Share-based compensation expense, amount 2,200       2,200 0
Shares issued in connection with convertible debenture offering, shares     250      
Shares issued in connection with convertible debenture offering, amount 62       62 0
Shares issued in connection with subordinate voting share offering, shares     23,000      
Shares issued in connection with subordinate voting share offering, amount 25,021       25,021 0
Shares issued in connection with conversion of convertible debentures, shares     375      
Shares issued in connection with conversion of convertible debentures, amount 75       75 0
Issuance of stock options associated with acquisitions 116       116  
Issuance of shares associated with acquisitions, shares     150      
Issuance of shares associated with acquisitions, amount 179       179  
Issuance of stock warrants 1,556       1,556  
Reduction in super voting share purchase price (39)       (39) 0
Exercise of warrants, shares     750      
Exercise of warrants, amount 210       210 0
Balance, shares at Dec. 31, 2020     57,617 203    
Balance, amount at Dec. 31, 2020 31,156       125,540 (94,384)
Net loss $ (24,677) $ 0 $ 0 $ 0 0 (24,677)
Exercise of options, shares 165   167      
Exercise of options, amount $ 48       48  
Share-based compensation expense, shares     1,290      
Share-based compensation expense, amount 1,355       1,355 0
Shares issued in connection with conversion of convertible debentures, shares     2,580      
Shares issued in connection with conversion of convertible debentures, amount 514       514 0
Issuance of shares associated with acquisitions, shares     30,641      
Issuance of shares associated with acquisitions, amount 43,259       43,259 0
Exercise of warrants, shares     1,511      
Exercise of warrants, amount 718       718  
Issuance of shares associated with subordinate voting share offering, shares     18,000      
Issuance of shares associated with subordinate voting share offering, amount 17,934       17,934  
Balance, shares at Dec. 31, 2021     111,806 203    
Balance, amount at Dec. 31, 2021 $ 70,307       $ 189,368 $ (119,061)